Related Experiment Videos
Studies on the experimental phenylketonuria in rats
Insights
This study created a rat model for phenylketonuria (PKU) by feeding high phenylalanine (Phe) diets. The rats exhibited PKU-like metabolic changes, offering insights into disease mechanisms.
Area of Science:
- Biochemistry
- Metabolic Disorders
- Animal Models
Background:
- Phenylketonuria (PKU) is a genetic disorder characterized by impaired phenylalanine metabolism.
- Understanding PKU's metabolic pathways is crucial for developing effective treatments.
- Animal models are essential for studying complex metabolic diseases like PKU.
Purpose of the Study:
- To establish and characterize a rat model mimicking human phenylketonuria (PKU).
- To investigate the metabolic alterations in rats fed a high phenylalanine (Phe) diet.
- To analyze the regulatory mechanisms of phenylalanine catabolism in experimental PKU.
Main Methods:
- Wistar albino pregnant rats were fed diets with varying phenylalanine (Phe) concentrations.
- Offspring were exposed to high Phe diets during specific developmental stages.
- Enzyme activities (Phe hydroxylase, transaminases) and metabolite levels (Phe, Tyr, PPA, PLA, HGA, o-HPAA) were analyzed.
Main Results:
- Rats exhibited suppressed liver Phe hydroxylase activity, elevated blood Phe, and urinary excretion of phenylpyruvic acid (PPA) and phenyllactic acid (PLA).
- The model showed excessive blood tyrosine (Tyr) and urinary homogentisic acid (HGA), resembling tyrosinemia alkaptonuria.
- Differences from human PKU included absent urinary o-hydroxyphenylacetic acid (o-HPAA) and variable PPA excretion.
Conclusions:
- The established rat model effectively mimics key metabolic aspects of human PKU and tyrosinemia.
- The model provides a platform for studying PKU pathogenesis and exploring therapeutic strategies.
- Analysis of enzyme activities revealed insights into the regulatory mechanisms of Phe catabolism in experimental PKU.
Abstract:
Wister albino pregnant rats were fed on pellets containing 3.5% L-phenylalanine (Phe) from 10 days before the expected date of birth. The diet was then switched to 7% Phe pellets at the third week after birth. Baby rats were reared with breast milk, and weaned at the end of the 4th week after birth; thereafter, they were reared with a normal diet for one week at the 5th week, and then were given 7% Phe diet from the 6th week. These rats, which were reared with a diet of high Phe, showed a similar metabolic pattern to that of human phenylketonuria (PKU) in the following aspects: definite suppression of the liver Phe hydroxylase activity, excretion of a large amount of phenylpyruvic acid (PPA) and phenyllactic acid (PLA) into urine, and an elvated level of blood Phe content. But, they had an excessive amount of blood tyrosine (Tyr), and concurrently excreted massive homogentisic acid (HGA) in urine just as in human tyrosinemia alkaptonuria. The absence of urinary o-hydroxyphenylacetic acid (o-HPAA) was also a distinct difference from human PKU. In some rats, mild inhibition of the liver Phe hydroxylase activity was observed. In other rats, there was no excretion of PPA into urine as in human hyperphenylalaninemia. Further, the regulatory mechanism of Phe catabolism of experimental PKU was discussed by analysing the enzyme activity of the liver Phe hydroxylase, phenylalanine-pyruvate (Phe-Pyr) transaminase and tyrosine alpha-ketoglutarate (Tyr-alpha-Kg) transaminase at different developmental stages of the rats.